Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Administration of antifibrinolytic medications, including tranexamic acid (TXA), may reduce head injury-related mortality. The effect of these medications on post-traumatic brain injury (TBI) inflammatory response is unknown. The goal of this study was to investigate the role of available antifibrinolytic medications on both systemic and cerebral inflammation after TBI.
Pubmed ID: 35319541